NCCN Oncology Policy Program

The NCCN Oncology Policy Program was initiated in 2009 to allow opportunities for discussion among oncology stakeholders to address relevant health policy concerns. The NCCN Oncology Policy Program has convened Policy Summits in areas such as comparative effectiveness research (CER), risk evaluation and mitigation strategies (REMS), patient advocacy, off-label drug use and compendia, biosimilars, molecular testing, clinical pathways, and data needs.

NCCN will continue these initiatives with summits focused on current policy topics. Details on NCCN’s current policy programs, as well as past summits, can be found below.

Please send any comments or questions regarding the NCCN Oncology Policy Program to